MAD4 is a direct target of miR-125b-5p. by Valentina Manfè (189797)

“…(E) Evaluation of the efficient MAD4 silencing in SeAx cells by Western Blot. (F) Decrease of the percentage of the annexin-V positive cells after MAD4 silencing in SeAx cells treated with bortezomib (48h) comparing to scrambled siRNA. …”

Time-course of BCR-ABL and SFK dephosphorylation after treatment with inhibitors. by Adam Obr (541887)

Experimental tank to follow the predatory behaviors displayed by snake <i>T</i>. <i>melanogaster</i> over the fish <i>X</i>. <i>variata</i>. by Javier Manjarrez (531011)

Panel A–D shows the posterior mean distribution of PfPR_2–10 by the prediction years of 1969–1989 in Namibia. by Abdisalan M. Noor (82579)

“…The grey shade represents areas where transmission is unsuitable due to aridity. All maps are at 5×5 km spatial resolution.</p>…”

Mean lesion number and GBF in gastric mucosa of rats pretreated with NaHS or L-cysteine combined with COX-1 and COX-2 inhibitors. by Marcin Magierowski (702795)

“…Asterisk and cross indicate a significant (p<0.05) increase in mean lesion number and decrease in GBF as compared to respective values obtained in vehicle-control animals. …”

Kidneys from Kif5b-Pax2KD (<i>Kif5bfl/-</i>:<i>Pax2-Cre</i>) embryos have a reduced cell proliferation rate. by Ju Cui (726069)

“…<i>Kif5b</i> deficiency significantly decreased BrdU incorporation in both ureteric bud and mesenchyme-derived epithelial structures, compared to wild type. …”

Plot showing average position (centroid) of predatory behavior of 18 treatments displayed by snake <i>T</i>. <i>melanogaster</i>, depending of three categories (few, median, many)... by Javier Manjarrez (531011)

Increased superoxide has a compartment specific effect on <i>clk-1</i> lifespan. by Claire E. Schaar (691681)

“…Deletion of either of the cytoplasmic <i>sod</i> genes (<i>sod-1</i>, <i>sod-5</i>) decreases <i>clk-1</i> lifespan. <b>C</b>. …”

Proportion of participants reporting a COVID-19 test among those reporting test-qualifying symptoms. by Mark S. Graham (4484317)

Immunohistochemical staining for endothelial cells (CD146) and astrocytes (GFAP) in the lumbar spinal cord of G93A mice at early and late stages of disease. by Svitlana Garbuzova-Davis (81764)

“…Scale bar in A, C, D, F is 50 µm; B, E, G is 25 µm.</p>…”

Table 1_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.docx by James P. Hardwick (20634155)

Image_6_Consecutive Hypoxia Decreases Expression of NOTCH3, HEY1, CC10, and FOXJ1 via NKX2-1 Downregulation and Intermittent Hypoxia-Reoxygenation Increases Expression of BMP4, NOT... by Yung-Yu Yang (9343376)

Image_5_Consecutive Hypoxia Decreases Expression of NOTCH3, HEY1, CC10, and FOXJ1 via NKX2-1 Downregulation and Intermittent Hypoxia-Reoxygenation Increases Expression of BMP4, NOT... by Yung-Yu Yang (9343376)

Image_8_Consecutive Hypoxia Decreases Expression of NOTCH3, HEY1, CC10, and FOXJ1 via NKX2-1 Downregulation and Intermittent Hypoxia-Reoxygenation Increases Expression of BMP4, NOT... by Yung-Yu Yang (9343376)

Image_7_Consecutive Hypoxia Decreases Expression of NOTCH3, HEY1, CC10, and FOXJ1 via NKX2-1 Downregulation and Intermittent Hypoxia-Reoxygenation Increases Expression of BMP4, NOT... by Yung-Yu Yang (9343376)

<i>Leishmania major</i> parasite loads in the draining inguinal lymph nodes (LNs) of different mice groups following NAIs therapy at six weeks post CL infection by using convention... by Alireza Badirzadeh (4248763)

Image 3_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tif by James P. Hardwick (20634155)

Image 5_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

Image 1_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

Image 4_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)